2-(azetidin-2-on-1-yl)alkanedioic acid derivatives as vasopressin V1a receptor antagonists

2-(azetidin-2-on-1-yl)alkanedioic acid derivatives of formula (I) are disclosed, wherein the variables are as defined in the specification. These compounds are suitable for use in the treatment of disease states responsive to antagonism of the vasopressin V1a receptor.

Saved in:
Bibliographic Details
Main Authors MILLER, MARVIN J, KOPPEL, GARY A, GUILLON, CHRISTOPHE D G, BRUNS, ROBERT F, HEINDEL, NED D
Format Patent
LanguageEnglish
Published 30.11.2006
Edition7
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:2-(azetidin-2-on-1-yl)alkanedioic acid derivatives of formula (I) are disclosed, wherein the variables are as defined in the specification. These compounds are suitable for use in the treatment of disease states responsive to antagonism of the vasopressin V1a receptor.
Bibliography:Application Number: NZ20020532033